查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447028

2030 年维吉尼亚市场预测：按类型、动物、分销管道、应用和地区进行的全球分析

Virginiamycin Market Forecasts to 2030 - Global Analysis By Type (Poultry, Aquaculture and Other Types), Animal (Companion Animals, Cattle, Swine and Other Animals), Distribution Channel, Application and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球维吉尼亚市场规模为 1.8505 亿美元，预计预测期内复合年增长率为 7.5%，到 2030 年将达到 3.0701 亿美元。

维吉尼亚是一种强效抗生素，也可用作牲畜和家禽的饲料添加剂，以促进生长并防止细菌感染。这种抗生素由两种密切相关的成分（维吉尼亚M1 和维吉尼亚S1）组成，属于链霉素组。此外，这些元素还可以透过阻止细胞内的蛋白质合成来抑制细菌生长。其对革兰氏阳性菌的出色功效使维吉尼亚霉素成为疾病预防和促进动物健康的宝贵工具。

根据美国兽医协会 (AVMA) 的说法，负责任地使用抗生素（包括维吉尼亚等化合物）对于确保农业环境中动物的健康和福祉至关重要。

增加畜牧业产量

全球畜产品需求不断成长是推动维吉尼亚市场的主要因素之一。随着世界人口持续增长以满足对肉类和乳製品日益增长的需求，高效和永续的畜牧生产变得越来越重要。此外，维吉尼亚是有利于集中畜牧业实践的主要因素，因为它有助于预防感染疾病并促进牲畜生长。

对抗生素抗药性的担忧

对抗生素抗药性的日益担忧是影响维吉尼亚市场的主要因素之一。在家畜中广泛且持续地使用维吉尼亚霉素等抗生素可能是导致抗药性细菌出现的因素。此外，抗药性细菌可以透过食物链传播给人类，不仅使牲畜而且使公共卫生面临风险。它还会降低抗生素的长期有效性。

扩大精准畜牧业的使用

在自动化、资料分析和感测器技术进步的推动下，维吉尼亚市场预计将受益于精准畜牧业的日益增长。此外，可以精确应用维吉尼亚和其他饲料添加剂，以最大限度地提高生长和健康结果。精密农业可以更精确地监测动物健康参数和饲料效率。

加强监管约束

加强对畜牧生产中抗生素使用的监管审查和收紧法规对维吉尼亚市场构成了严重威胁。对抗生素抗药性的担忧导致各国政府和国际组织制定更严格的法规，这可能会限制维吉尼亚的供应和使用。此外，市场参与企业还面临遵守不断变化的监管标准的挑战。

COVID-19 的影响：

由于供应链中断、劳动力短缺和经济不确定性影响了整个农业和畜牧业，COVID-19 大流行对维吉尼亚市场产生了重大影响。疫情带来的关闭和限製造成了物流挑战，阻碍了维吉尼亚等饲料添加剂的生产和分销。此外，由于经济衝击，一些家牛生产者重新考虑了他们的支出，这可能会影响这些添加剂的市场。

预计在预测期内家禽市场将成为最大的市场

家禽养殖占维吉尼亚市场的最大份额。家禽业广泛使用维吉尼亚作为饲料添加剂，以促进生长并保护鸡和其他家禽免受细菌感染。由于人口增长和饮食偏好的变化，世界对家禽产品的持续需求，对有效和永续的家禽养殖的需求正在增加。此外，维持鸡群健康和产量的有用工具是维吉尼亚，因为它具有对抗革兰氏阳性菌的效力。

牛和家禽饲料添加剂领域预计在预测期内复合年增长率最高。

牛和家禽饲料添加剂是复合年增长率最高的维吉尼亚市场。由于对肉类和家禽产品的需求不断增加以及对永续动物生产方法的需求，该市场正在显着扩大。维吉尼亚是一种抗生素饲料添加剂，因其治疗和预防牛和家禽疾病（如球虫和坏死性小肠结肠炎）的能力而受到高度重视。此外，它还能刺激生长，提高饲料转换效率，促进体重增加，并改善动物的整体健康状况。

占比最大的地区：

北美可能占据维吉尼亚市场的最大份额。北美地区畜牧业发达，对肉禽产品的需求量大，是维吉尼亚的主要消费国。以维吉尼亚作为牛和家禽饲料添加剂也受到该地区严格的食品安全和动物健康法规的影响。此外，推广永续动物生产方法也是北美的重点优先事项，支持该地区维吉尼亚市场的扩张。

复合年增长率最高的地区：

预计亚太地区维吉尼亚市场的复合年增长率最高。在亚太地区，作为牛和家禽饲料添加剂的维吉尼亚的需求大幅增加。这一增长的主要驱动力是由于人口增长、可支配收入增加和饮食偏好变化而导致的肉类和家禽产品消费量的增加。此外，该地区正在转向更加集中的畜牧方式，因此需要使用维吉尼亚等抗生素来预防感染疾病并促进生长。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球维吉尼亚市场：依类型

  • 家禽
  • 水产养殖
  • 其他类型

第六章全球维吉尼亚市场：依动物分类

  • 伴同性动物
  • 牛
  • 猪
  • 其他动物

第七章全球维吉尼亚市场：按分销管道

  • 医院药房
  • 零售药房
  • 网路药房

第八章全球维吉尼亚市场：依应用分类

  • 坏死性小肠结肠炎
  • 球虫
  • 生长刺激
  • 牛和家禽饲料添加剂
  • 其他用途

第九章全球维吉尼亚市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Elanco
  • Merck Animal Health
  • Ceva
  • Merial
  • Bayer Animal Health
  • Phibro Animal Health Corporation
  • Vetoquinol
  • Boehringer Ingelheim
  • Virbac
  • Zoetis
Product Code: SMRC25289

According to Stratistics MRC, the Global Virginiamycin Market is accounted for $185.05 million in 2023 and is expected to reach $307.01 million by 2030 growing at a CAGR of 7.5% during the forecast period. Virginiamycin is a strong antibiotic that is also used as a feed additive in livestock and poultry farming to boost growth and guard against bacterial infections. Virginiamycin M1 and Virginiamycin S1, its two closely related components, make up this antibiotic that is a member of the streptogramin group. Additionally, these elements suppress bacterial growth by preventing protein synthesis in the cells. Due to its exceptional efficacy against Gram-positive bacteria, Virginiamycin is a valuable tool for disease prevention and enhancing animal health in general.

According to the American Veterinary Medical Association (AVMA), the responsible use of antibiotics, including compounds such as Virginiamycin, is crucial in ensuring the health and well-being of animals in agricultural settings.

Market Dynamics:

Driver:

Increasing production of livestock

The growing demand for livestock products worldwide is one of the major factors driving the Virginiamycin market. To meet the rising demand for meat and dairy products, efficient and sustainable livestock production is becoming more and more important as the world's population continues to rise. Moreover, virginiamycin is a major factor in favor of intensive animal farming practices because it helps to prevent infections and promote growth in livestock.

Restraint:

Antibiotic resistance concerns

The increasing worry about antibiotic resistance is one of the major factors affecting the Virginiamycin market. The widespread and ongoing use of antibiotics, such as Virginiamycin, in cattle may be a factor in the emergence of bacterial strains that are resistant. Furthermore, due to the fact that resistant bacteria may spread to humans via the food chain, this puts public health at risk in addition to that of animals. It also reduces the antibiotics' long-term efficacy.

Opportunity:

Growing use of accurate livestock production

The market for virginiamycin is expected to benefit from the increasing use of precision livestock farming, which is being fueled by developments in automation, data analytics, and sensor technologies. Moreover, virginiamycin and other feed additives can be applied precisely to maximize growth and health outcomes. Precision farming makes it possible to monitor animal health parameters and feed efficiency more precisely.

Threat:

Growing restraints on regulations

The increasing regulatory scrutiny and tightening restrictions on the use of antibiotics in livestock farming pose a serious threat to the Virginiamycin market. Stricter regulations are being put in place by governments and international organizations in response to worries about antibiotic resistance, which may restrict the supply and use of Virginiamycin. Furthermore, market participants face challenges in adhering to changing regulatory standards.

Covid-19 Impact:

Due to supply chain disruptions, labor shortages, and economic uncertainties that have impacted the entire agriculture and livestock industry, the COVID-19 pandemic has had a significant impact on the Virginiamycin market. Lockdowns and restrictions brought on by the pandemic created logistical difficulties that hampered the manufacture and distribution of feed additives, such as Virginiamycin. Moreover, some cattle producers have reevaluated their expenditures as a result of the economic fallout, which could affect the market for these additives.

The Poultry segment is expected to be the largest during the forecast period

In the market for Virginiamycin, poultry farming has the largest share. To encourage growth and guard against bacterial infections in hens and other poultry species, the poultry industry uses Virginiamycin as a feed additive liberally. The need for effective and sustainable poultry farming practices has grown as a result of the world's constant demand for poultry products, which is being driven by population growth and shifting food preferences. Additionally, a useful tool for preserving the wellbeing and output of chicken flocks is Virginiamycin, due to its potency against Gram-positive bacteria.

The Feed Additive for Cattle and Poultry segment is expected to have the highest CAGR during the forecast period

Feed Additive for Cattle and Poultry is the Virginiamycin market segment with the highest CAGR. Due to the rising demand for meat and poultry products as well as the necessity of using sustainable animal production methods, this market is expanding significantly. The antibiotic feed additive virginiamycin is highly prized for its ability to treat and prevent diseases in cattle and poultry, including coccidiosis and necrotic enteritis. Furthermore, it also stimulates growth, increasing feed conversion effectiveness, encouraging weight gain, and improving the general health of the animal.

Region with largest share:

North America is probably the region with the largest share of the Virginiamycin market. Because of its well-established livestock industry and strong demand for meat and poultry products, North America is a major consumer of Virginiamycin. The adoption of Virginiamycin as a feed additive for cattle and poultry is also influenced by the region's strict regulations regarding food safety and animal health. Moreover, the promotion of sustainable animal production methods is another major priority in North America, which supports the expansion of the Virginiamycin market there.

Region with highest CAGR:

The Asia-Pacific region is anticipated to have the highest CAGR in the Virginiamycin market. The demand for Virginiamycin as a feed additive for cattle and poultry is rising significantly in the Asia-Pacific area. The growing population, rising disposable income, and shifting dietary preferences-which result in a greater consumption of meat and poultry products-are the main drivers of this growth. Furthermore, the area is witnessing a transition towards more intensive methods of animal husbandry, thereby requiring the application of antibiotics such as Virginiamycin to prevent infections and enhance growth.

Key players in the market

Some of the key players in Virginiamycin market include Elanco, Merck Animal Health, Ceva, Merial, Bayer Animal Health, Phibro Animal Health Corporation, Vetoquinol, Boehringer Ingelheim, Virbac and Zoetis.

Key Developments:

In November 2023, CEVA Logistics completed its acquisition of Stellar Value Chain. CEVA acquired a 96% stake in the Mumbai-based warehousing and transportation specialists from an affiliate of private equity form Warburg Pincus and other shareholders. The acquisition adds to CEVA's existing presence in India, allowing for the delivery of holistic supply chain services to customers across the Asia Pacific region and beyond.

In August 2023, Merck Animal Health announced Dec. 6 that it has acquired Prondil S.A., a privately held company specializing in the development and manufacturing of animal health vaccines for livestock. Specific terms of the agreement were not disclosed. Prondil, located in Montevideo, Uruguay, is an internationally recognized supplier of antigens and vaccines for veterinary use. The company's wide range of products is sold in more than 20 countries.

In May 2023, Elanco Animal Health Incorporated has entered into an agreement with Aptimmune Biologics, Inc., as the exclusive distributor of their porcine reproductive and respiratory syndrome inactivated, or killed, vaccine based on Aptimmune's Barricade technology platform in the United States. An inactivated vaccine is one consisting of virus particles, bacteria or other pathogens that have been grown in culture and then killed to destroy disease-producing capacity.

Types Covered:

  • Poultry
  • Aquaculture
  • Other Types

Animals Covered:

  • Companion Animals
  • Cattle
  • Swine
  • Other Animals

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Applications Covered:

  • Necrotic enteritis
  • Coccidiosis
  • Growth Stimulation
  • Feed Additive for Cattle and Poultry
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • sAsia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Virginiamycin Market, By Type

  • 5.1 Introduction
  • 5.2 Poultry
  • 5.3 Aquaculture
  • 5.4 Other Types

6 Global Virginiamycin Market, By Animal

  • 6.1 Introduction
  • 6.2 Companion Animals
  • 6.3 Cattle
  • 6.4 Swine
  • 6.5 Other Animals

7 Global Virginiamycin Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacies
  • 7.3 Retail Pharmacies
  • 7.4 Online Pharmacies

8 Global Virginiamycin Market, By Application

  • 8.1 Introduction
  • 8.2 Necrotic enteritis
  • 8.3 Coccidiosis
  • 8.4 Growth Stimulation
  • 8.5 Feed Additive for Cattle and Poultry
  • 8.6 Other Applications

9 Global Virginiamycin Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Elanco
  • 11.2 Merck Animal Health
  • 11.3 Ceva
  • 11.4 Merial
  • 11.5 Bayer Animal Health
  • 11.6 Phibro Animal Health Corporation
  • 11.7 Vetoquinol
  • 11.8 Boehringer Ingelheim
  • 11.9 Virbac
  • 11.10 Zoetis

List of Tables

  • Table 1 Global Virginiamycin Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 4 Global Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 5 Global Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 6 Global Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 7 Global Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 8 Global Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 9 Global Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 10 Global Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 11 Global Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 12 Global Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 13 Global Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 14 Global Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 15 Global Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 16 Global Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 17 Global Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 18 Global Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 19 Global Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 20 Global Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 21 North America Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
  • Table 22 North America Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 23 North America Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 24 North America Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 25 North America Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 26 North America Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 27 North America Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 28 North America Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 29 North America Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 30 North America Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 31 North America Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 32 North America Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 33 North America Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 34 North America Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 35 North America Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 36 North America Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 37 North America Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 38 North America Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 39 North America Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 40 North America Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 Europe Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Europe Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 43 Europe Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 44 Europe Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 45 Europe Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 46 Europe Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 47 Europe Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 48 Europe Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 49 Europe Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 50 Europe Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 51 Europe Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 52 Europe Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 53 Europe Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 54 Europe Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 55 Europe Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 56 Europe Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 57 Europe Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 58 Europe Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 59 Europe Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 60 Europe Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 61 Asia Pacific Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Asia Pacific Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 63 Asia Pacific Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 64 Asia Pacific Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 65 Asia Pacific Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 66 Asia Pacific Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 67 Asia Pacific Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 68 Asia Pacific Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 69 Asia Pacific Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 70 Asia Pacific Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 71 Asia Pacific Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 72 Asia Pacific Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 73 Asia Pacific Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 74 Asia Pacific Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 75 Asia Pacific Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 76 Asia Pacific Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 77 Asia Pacific Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 78 Asia Pacific Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 79 Asia Pacific Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 80 Asia Pacific Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 81 South America Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 South America Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 83 South America Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 84 South America Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 85 South America Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 86 South America Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 87 South America Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 88 South America Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 89 South America Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 90 South America Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 91 South America Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 92 South America Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 93 South America Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 94 South America Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 95 South America Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 96 South America Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 97 South America Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 98 South America Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 99 South America Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 100 South America Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 101 Middle East & Africa Virginiamycin Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 Middle East & Africa Virginiamycin Market Outlook, By Type (2021-2030) ($MN)
  • Table 103 Middle East & Africa Virginiamycin Market Outlook, By Poultry (2021-2030) ($MN)
  • Table 104 Middle East & Africa Virginiamycin Market Outlook, By Aquaculture (2021-2030) ($MN)
  • Table 105 Middle East & Africa Virginiamycin Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 106 Middle East & Africa Virginiamycin Market Outlook, By Animal (2021-2030) ($MN)
  • Table 107 Middle East & Africa Virginiamycin Market Outlook, By Companion Animals (2021-2030) ($MN)
  • Table 108 Middle East & Africa Virginiamycin Market Outlook, By Cattle (2021-2030) ($MN)
  • Table 109 Middle East & Africa Virginiamycin Market Outlook, By Swine (2021-2030) ($MN)
  • Table 110 Middle East & Africa Virginiamycin Market Outlook, By Other Animals (2021-2030) ($MN)
  • Table 111 Middle East & Africa Virginiamycin Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 112 Middle East & Africa Virginiamycin Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 113 Middle East & Africa Virginiamycin Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 114 Middle East & Africa Virginiamycin Market Outlook, By Online Pharmacies (2021-2030) ($MN) Table 115 Middle East & Africa Virginiamycin Market Outlook, By Application (2021-2030) ($MN)
  • Table 116 Middle East & Africa Virginiamycin Market Outlook, By Necrotic enteritis (2021-2030) ($MN)
  • Table 117 Middle East & Africa Virginiamycin Market Outlook, By Coccidiosis (2021-2030) ($MN)
  • Table 118 Middle East & Africa Virginiamycin Market Outlook, By Growth Stimulation (2021-2030) ($MN)
  • Table 119 Middle East & Africa Virginiamycin Market Outlook, By Feed Additive for Cattle and Poultry (2021-2030) ($MN)
  • Table 120 Middle East & Africa Virginiamycin Market Outlook, By Other Applications (2021-2030) ($MN)